than 2-fold) increase in ⌬90 could change the terminal
Figure 1. High CDC2/cyclinB1 Activity Inhibits Sister Chromatid Separation and Segregation in Xenopus Extracts but Not Securin Degradation
(A) Effects of nondegradable cyclinB1 (⌬90) and the CDC2 inhibitor roscovitine on anaphase and mitotic exit. CSF-arrested Xenopus egg extracts supplemented with rhodamine-tubulin and Xenopus sperm nuclei were cycled through interphase and rearrested at metaphase. ⌬90 and roscovitine were added at 25 min and 10 min, respectively, before the addition of Ca 2ϩ . To evaluate anaphase occurrence, whole spindles and individual chromosomes were visualized by fluorescence microscopy. Spindle disassembly and chromosome decondensation were used as readout for mitotic exit. Note that sister chromatid separation and segregation did actually occur at 0 and 20 nM ⌬90 but were not evaluated, because 50 min after calcium addition, these extracts had long exited mitosis.
(B) Histone H1 kinase assay for selected extracts as used in (A). (C) APC is not inhibited by high-⌬90 concentrations.
35 S-labeled Xenopus securin and an N-terminal fragment of cyclinB1 were generated by in vitro translation and added to CSF-extracts. The kinetics of securin degradation after Ca 2ϩ addition were measured in the presence (500 nM) or absence of human ⌬90 (upper panel). In the lower panel, degradation of cyclinB1 was detected 45 min after Ca 2ϩ addition. The extract contained 32 to 500 nM human ⌬90 (lanes 2 to 6; 2-fold increase in concentration between each lane), 82 to 1300 nM sea urchin ⌬90 (lanes 7 to 11), or 50 to 800 nM unlabeled cyclinB1 fragment (lanes 12 to 16). Lane 1: Negative control without Ca 2ϩ addition.
arrest phenotype, these observations did not clarify We conclude that two different concentration ranges of nondegradable cyclinB1 cause two different effects. whether the spindles failed to move chromosomes toward the poles or whether the anaphase block was acAt the lower concentration range (40 to 80 nM), sister chromatid separation and segregation occur efficiently, companied by a failure to dissolve sister chromatid cohesion. To address this issue, chromosomes were but mitotic exit is blocked; at the higher concentration range (above 120 nM), sister separation, and hence segreisolated from extracts 50 min after the initiation of anaphase and visualized by fluorescence microscopy regation, are inhibited as well. It is important to note that ⌬90 completely blocks anaphase at a concentration at high magnification (Funabiki and Murray, 2000) . This analysis revealed that at a ⌬90 concentration of 40 to only 3-fold higher than the minimal concentration necessary to prevent spindle disassembly and chromosome 80 nM, almost all chromosomes displayed a one-chromatid configuration, indicating that sister separation decondensation. The most trivial explanation for the inhibition of anahad taken place ( Figure 1A , rows 4 and 5). In contrast, at a ⌬90 concentration of 120 nM and above, most chrophase by ⌬90 would be if ⌬90-despite missing the destruction box-was still a poor APC substrate. In this mosomes displayed a butterfly-like shape characteristic of chromosomes composed of two unseparated chrocase, it might compete for securin degradation at high concentrations. To test this possibility, we compared matids ( Figure 1A, rows 6 to 8) . the degradation of 35 S-labeled securin in extracts lacking ⌬90 or containing it at a very high concentration (500 nM). The kinetics of degradation in both extracts were very similar ( Figure 1C, upper panel) . We also tested whether different ⌬90 preparations could inhibit the degradation of an N-terminal fragment of cyclinB1, another well-documented APC substrate (Glotzer et al., 1991; King et al., 1996b). Human or sea urchin ⌬90 did not compete for the degradation of the 35 S-labeled fragment, while an unlabeled fragment did so efficiently (Figure 1C, lower panel) . We conclude that ⌬90 is neither an APC substrate nor an APC inhibitor, and therefore must inhibit anaphase by a mechanism other than competitive inhibition of securin degradation.
Next, we used a specific CDC2 inhibitor, roscovitine, to ask whether ⌬90 exerts its inhibitory effect by activating CDC2 or via an as yet unknown function. When chromatid separation and segregation were blocked in a high-⌬90 extract, addition of roscovitine rescued both events with high efficiency ( Figure 1A , row 9). At the same time, roscovitine reduced the CDC2 activity to the level of a low-⌬90 extract, as determined by histone H1 kinase assay ( Figure 1B ). This experiment demonstrated that nondegradable cyclinB1 acts by activating CDC2 
To address this issue, we developed an in vitro separase
The assay was performed with wild-type separase (WT; lanes 1, 3, activity assay. Plasmids coding for human securin and (Figure 2A , demonstrate that in extracts with high CDC2 activity, separase is kept inactive despite the absence of securin, lane 4). As the active site lies far from where cleavage occurs, this result implies that the cleavage of separase thus providing one possible explanation for the block of anaphase under these conditions. is autocatalyzed (H.Z., O.S., and M.W.K., unpublished data). Self-cleavage of separase thus serves as a readWe noticed that in some cases, a fraction of separase was already cleaved initially, despite being fully inhibout for separase activity. Reisolation of securin-free separase from the Xenopus extract yielded a preparation ited, as measured by the activity assay. As the same degree of cleavage was detectable already in crude that cleaved cohesin hSCC1 efficiently (Figure 2A , lanes 5 to 8). This activity assay put us in a position to ask extracts, we assume that it occurred during synchronization of the cells. Cleavage to different extents was whether high-⌬90 extract had any impact on separase activity. As seen before, separase cleaved itself and observed even for endogenous separase in untransfected cells (data not shown). The reason for these variacohesin effectively when treated with a low-⌬90 extract ( Figure 2B, lanes 1 and 4) . Interestingly, both cleavage tions is not known but may indicate that self-cleaved separase can be reinhibited (see below). events were largely suppressed upon incubation in a and tested for separase activity by our standard assay.
( Figure 4B, lanes 19 and 20) . PM-4, on the other hand, was inactivated by high CDC2 activity, albeit less so As seen above, wild-type separase cleaved itself and cohesin hSCC1 efficiently at low but not at high CDC2 activthan wild-type separase ( Figure 4B, lanes 21 and 22) . These results demonstrate that in vitro inhibition of ity ( Figure 4B, lanes 1, 2, 15, and 16 tion of separase alone is sufficient to rescue sister chromatid separation in an extract with high CDC2 activity. The negative effect of a high-⌬90 extract on sister separation therefore seems to be mediated mostly, if not exclusively, by the inhibition of separase. Based on the above results, we can exclude the caveat that cohesin hSCC1 might be rendered resistant to cleavage in an extract with high CDC2 activity.
A second mutant, PM-4, caused some loss of cohesion, albeit less than PM-2 (38% versus 68%; Figure 5A , rows 5 and 6). When the amount of added separase was reduced, the difference between PM-2 and -4 became more pronounced and resembled more closely the situation of the cohesin hSCC1 cleavage assay ( Figure 4B and data not shown). Thus, phosphorylation site 4 (Thr1346) seems to have a minor effect on separase activity, while Ser1126 appears to be the major regulatory site. 293T cells, we found that 54 (Ϯ0.9)% of affinity-purified separase was phosphorylated at Ser1126 in nocodaSince the biochemical experiments utilized human separase, we modified the existing assay to examine the zole. 125 min after release from nocodazole, the level of phosphorylation dropped to 30 (Ϯ0.9)% (data not separation of human metaphase chromosomes in Xenopus extracts. The maximal degree of sister chromatid shown). Although affinity purification of separase gave extremely clean peptide spectra, the transfection experseparation that was observed in this system under optimal conditions (low-⌬90 extract plus saturating level of iment had the disadvantage that it involved high overexpression of separase and that the synchronization of PM-2/4) was about 70% (data not shown). In the presence of wild-type separase and high concentrations of the cells was less efficient. We therefore asked whether we could also measure phosphorylation of peptide ⌬90, only 2.7% of the chromosomes separated ( Figure  5A, row 2) . Likewise, separation was negligible when Glu1115-Lys1130 under more physiological conditions and with as little manipulation as possible (i.e., with catalytically inactive separase was added (0.4%) or when separase was omitted (1.4%; Figure 5A , rows 1 no purification of separase). Crude high speed extracts from synchronized, untransfected HeLaS3 cells were and 3). In contrast, PM-2 led to maximal separation of sister chromatids (68%) under the same conditions directly submitted to SDS-PAGE and the regions, where full-length separase and its N-terminal cleavage frag-( Figure 5A, row 5) . Similar results were obtained with PM-2/4 and PM-2 Asp ; they caused 68% and 66% separament migrated as judged by Western blotting, were cut from the gel. Because separase underwent self-cleavtion, respectively ( Figure 5A, rows 4 and 7) . A Western blot for separase was performed to assure that similar age upon release from nocodazole arrest ( Figure 6A ), both gel pieces of each time point were pooled and amounts of the various separases had been used in the experiment ( Figure 5B) . analyzed as described above. Remarkably, in using this technique, the Glu1115-Lys1130 peptides of endogeWe conclude that preventing inhibitory phosphoryla- The experiments also showed that separase that is altantly, 80 min after release from nocodazole, only 79% of separase remained phosphorylated, and this level ready active can be reinhibited by either of the two inhibitory events. In the case of phosphorylation, it redropped further to 67% at 110 min ( Figures 6B and 6C ). This change corresponds to a 5-fold decrease in the mains to be determined if the reinhibition of cleaved separase is as efficient as for uncleaved separase. ratio of phosphorylated to unphosphorylated peptide. Considering that even at the 110 min time point, 40%
Separase Ser1126 Is Quantitatively
We also compared how efficiently wild-type and mutant separase were inhibited by securin. When wild-type of the cells were still in mitosis as determined by FACS analysis (Figures 6A and 6B) , these values represent separase and PM-2/4 were used in equal amounts, as judged by anti-separase Western blot ( Figure 4B , lanes approximately a 2-fold underestimation of the actual extent of dephosphorylation upon exit from mitosis. 15 and 17), both were inhibited at the same concentration of securin ( Figure 6B ). Thus, wild-type separase and Overall, the relative change in the phosphorylation status of Ser1126 coincided well with the relative change the PM-2/4 mutant bind securin with similar affinities. This supports the notion that PM-2/4 is active in a highof the cyclinB1 level (compare Figures 6A and 6B) Figures 6D and 6E ). As controls, we found that auroraA phosphorylated myelin basic protein and that 1999). In this paper, we extend these findings to obtain a more complete picture for the control of anaphase CaMKII and polo underwent efficient autophosphorylation (data not shown). onset in vertebrates. Using Xenopus egg extracts to recapitulate anaphase in vitro, we discovered that CDC2 not only prevents mitotic exit but also blocks the dissoluBoth Securin Binding and Phosphorylation Can tion of sister chromatid cohesion. This inhibition is due Independently Inhibit Separase to the inactivation of separase by phosphorylation at one We have shown that separase activity can be blocked major site. Mutation of the respective serine to alanine is by phosphorylation when securin is not present. But can sufficient to render both the cleavage of cohesin hSCC1 securin inhibit separase independent of the phosphoryby separase and the separation of sister chromatids lation state of separase? And can separase that has resistant to high CDC2 activity. In vivo, the inhibitory already been activated and has therefore cleaved itself site of separase is quantitatively phosphorylated at be reinhibited by any of the two inhibitory mechanisms? metaphase arrest and becomes partly dephosphoryTo address these questions, we first generated active lated upon release into anaphase. separase by treating a securin/separase complex with a low-⌬90 extract. The fact that separase had completely cleaved itself after this treatment demonstrated that it A Revised Model for Sister Chromatid Separation Our results suggest an extended model of sister chrowas indeed active at this state (data not shown). Active separase was then incubated with either recombinant matid separation in vertebrates as shown in Figure 7C . Before anaphase onset, separase is subject to a 2-fold securin or a high-⌬90 extract and assayed for its ability to cleave cohesin hSCC1 . Figure 7 illustrates that securin inhibition: on one hand, there is the established inhibition of separase by association with the inhibitor securin; and a high-⌬90 extract each caused reinhibition of separase activity, although the reinhibition by phosphorylaon the other hand, there is a hitherto unknown inhibitory phosphorylation, which is due to the high CDC2/ tion was less complete ( Figure 7A, lane 3; Figure 7B,  lanes 2 and 3) . Approximately a 2.5-fold molar excess cyclinB1 activity at this stage of the cell cycle. According to this model, securin degradation on its own is not of recombinant securin was sufficient to fully suppress cohesin hSCC1 cleavage ( Figure 6B ). The respective control sufficient to activate separase. Before sister chromatid separation can take place, the inhibitory phosphorylatreatments left separase active ( Figure 6A , lane 1; Figure  6B , lane 1). Likewise, separase did not become active tion has to be removed as well. One scenario of how this might happen is that APC when consecutively treated with high-⌬90 extract twice ( Figure 6A, lane 2) . causes destruction of a part of cyclinB1, thereby causing a drop in CDC2 activity. This would allow a putative, In summary, separase can be inhibited by either securin or an extract with high CDC2 activity, and these constitutively active phosphatase to gain the upper hand, which would result in dephosphorylation and actidid not detect a complete dephosphorylation of separase upon release from nocodazole. Alternatively, the vation of separase. Several observations support this explanation. In Xenopus extracts, histone H1 kinase acpostulated phosphatase (see above) might be independently regulated and become active at the metaphasetivity drops to interphase level before anaphase becomes visible (Shamu and Murray, 1992 insects, and nematodes). Nonetheless, we still think and Ferrell, 1998). It is therefore possible that the inhibithat, at least in vertebrates, the negative regulation of tory phosphorylation of separase is sustained by MAPK separase by phosphorylation is conserved. This is based for some time even after CDC2/cyclinB1 levels have on the finding that human PM-2 is sufficient to rescue begun to drop. Such a model might help to explain the separation of Xenopus chromosomes in high-⌬90 exfact that anaphase commences only about 25 min after tract, thus demonstrating that in frogs, separase is also the mitotic checkpoint is inactivated and degradation inhibited by phosphorylation (O.S., H.Z., and M.W.K., of cyclinB1 is detectable (Rieder et al., 1994; Clute and unpublished data). Pines, 1999).
The lack of obvious sequence conservation does not For the other kinases tested, our experiments proin itself exclude the possibility that the separases of vided a more definite answer. Polo, auroraA, and CaMKII fungi, plants, insects, and nematodes might also be regwere unable to phosphorylate Ser1126 of separase in ulated by phosphorylation. For example, lack of the vitro. Furthermore, in vivo, the phosphorylation status S-phase cyclins CLB5 and CLB6 in budding yeast byof Ser1126 is low in S-phase when the cyclinA2 level is passes the requirement of securin degradation for anahigh (Figure 6 ). These results lead us to conclude that phase but not of cohesin cleavage (Meyn and Holloway, Polo, auroraA, CaMKII, and CDK2/cyclinA are unable to 2000). This observation suggests that these cyclins inhibit separase, at least not via phosphorylation of the might be required to downregulate separase activity in S major inhibitory site that we have identified. . While different kiresult, it was proposed that anaphase onset must be nases might inhibit separase, the basic dual inhibition controlled by an additional regulatory mechanism that model for sister chromatid separation may be applicable does not require securin. Such a mechanism has reto several phyla. cently been discovered by Nasmyth and coworkers, who 
and Antibodies
However, the phosphorylation sites are not conserved Full-length human separase was PCR-amplified from a human fetal thymus cDNA library (Clontech) using the following primers: 5Ј-ATG in human SCC1.
